Bowman & Co S.C. Has $1.61 Million Position in UnitedHealth Group Incorporated $UNH

Bowman & Co S.C. boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,133 shares of the healthcare conglomerate’s stock after acquiring an additional 567 shares during the quarter. Bowman & Co S.C.’s holdings in UnitedHealth Group were worth $1,608,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the stock. Westmount Partners LLC raised its stake in UnitedHealth Group by 65.4% during the second quarter. Westmount Partners LLC now owns 1,057 shares of the healthcare conglomerate’s stock worth $330,000 after acquiring an additional 418 shares in the last quarter. Beacon Financial Group grew its holdings in shares of UnitedHealth Group by 2.1% during the second quarter. Beacon Financial Group now owns 2,646 shares of the healthcare conglomerate’s stock worth $826,000 after purchasing an additional 55 shares during the last quarter. Burr Financial Services LLC grew its holdings in shares of UnitedHealth Group by 80.8% during the second quarter. Burr Financial Services LLC now owns 940 shares of the healthcare conglomerate’s stock worth $293,000 after purchasing an additional 420 shares during the last quarter. Czech National Bank grew its holdings in shares of UnitedHealth Group by 4.9% during the second quarter. Czech National Bank now owns 221,726 shares of the healthcare conglomerate’s stock worth $69,172,000 after purchasing an additional 10,351 shares during the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt grew its holdings in shares of UnitedHealth Group by 106.0% during the second quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 82,512 shares of the healthcare conglomerate’s stock worth $25,741,000 after purchasing an additional 42,450 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on UNH. TD Securities restated a “hold” rating and set a $308.00 target price (down previously from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Wells Fargo & Company decreased their target price on UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. Wolfe Research decreased their price target on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating on the stock in a report on Tuesday, May 20th. Royal Bank Of Canada decreased their price target on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Finally, HSBC reiterated a “reduce” rating and issued a $270.00 price target (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $358.95.

UnitedHealth Group Stock Down 1.3%

Shares of UnitedHealth Group stock opened at $348.05 on Tuesday. The business’s 50 day simple moving average is $292.87 and its 200 day simple moving average is $367.43. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The firm has a market cap of $315.22 billion, a PE ratio of 15.08, a P/E/G ratio of 2.30 and a beta of 0.44. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period in the prior year, the business posted $6.80 EPS. The firm’s quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s payout ratio is 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.